Chartwell Investment Partners, LLC Novo Cure LTD Transaction History

Chartwell Investment Partners, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$75.08 - $121.99 $222,462 - $361,456	-2,963 Closed	0 $0
Q4 2020 Feb 09, 2021	SELL	$112.16 - $174.14 $1.71 Million - $2.65 Million	-15,214 Reduced 83.7%	2,963 $513,000
Q2 2020 Jul 29, 2020	SELL	$57.2 - $74.41 $379,178 - $493,263	-6,629 Reduced 26.72%	18,177 $1.08 Million
Q1 2020 Apr 30, 2020	BUY	$57.05 - $95.75 $151,867 - $254,886	2,662 Added 12.02%	24,806 $1.67 Million
Q4 2019 Jan 29, 2020	BUY	$68.3 - $93.8 $1.51 Million - $2.08 Million	22,144 New	22,144 $1.87 Million

290

75.6M

1.77M

538K

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $2.03B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

Get notified when there are updates to the investment portfolio of Chartwell Investment Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Chartwell Investment Partners, LLC with notifications on news.